Creative Enzymes Pioneers AI Platform, Accelerating Industrial Biocatalysis and Enzyme Innovation

Creative Enzymes, a global leader in enzyme technology, has unveiled an advanced AI-integrated biocatalysis platform to address critical development bottlenecks in biomanufacturing. This innovative solution combines cutting-edge computational enzyme engineering with practical process development, delivering AI-Driven Biocatalysis Solutions that are predictable in silico and robust for industrial application.

The platform significantly accelerates enzyme development, reducing the "design-build-test-learn" cycle from 12-24 months to just 8-12 months. AI's predictive power lowers R&D costs, mitigates process failure risks, and opens new routes to previously inaccessible molecules. Its structured, data-driven approach spans discovery, industrial scaling, and green biocatalysis, ensuring empirically validated decisions from target analysis to scale-up.

Demonstrated by a successful transaminase engineering case study, this platform enhances sustainability by minimizing solvent use, reducing energy consumption, and simplifying purification. Its capabilities are set to transform pharmaceuticals, agrochemicals, food, fine chemicals, and personal care sectors by enabling high-value conversions and greener, more efficient production processes.